Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Joo-Heung Lee"'
Autor:
Se Jin Oh, MD, Seung Hwan Oh, MD, Ji-Young Jun, MD, Ji-Hye Park, MD, Jong Hee Lee, MD, PhD, Dong-Youn Lee, MD, PhD, Joo-Heung Lee, MD, PhD, Jun-Mo Yang, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 3, Iss 5, Pp 376-378 (2017)
Externí odkaz:
https://doaj.org/article/9ec09944bd384b14ac8a416960b715ed
Publikováno v:
Indian journal of dermatology. 67(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2f4d7014a4f9f3dfe0ccfd502e3f8d1
https://pubmed.ncbi.nlm.nih.gov/36386070
https://pubmed.ncbi.nlm.nih.gov/36386070
Autor:
Hyun Je Kim, Dong-Youn Lee, Se Jin Oh, Young Hwan Choi, Jong Hee Lee, Ji-Hye Park, Joo-Heung Lee
Publikováno v:
Dermatology. 237:457-463
Background: Acneiform eruption is the most common cutaneous adverse event associated with cetuximab. As it can affect quality of life and adversely affect chemotherapy schedule, additional medical care is required. Objectives: To investigate the adhe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae266064c353bde02166eee359c07d93
https://doi.org/10.1159/000511623
https://doi.org/10.1159/000511623
Publikováno v:
The Journal of Dermatology
Psoriasis, a chronic inflammatory skin disease, negatively impacts patients’ quality of life (QoL). This randomized, phase III, double‐blind, placebo‐controlled, multicenter study evaluated the efficacy and safety of brodalumab, a human anti‐
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6be152517ddbaf88536839ee7a6dc32e
http://europepmc.org/articles/PMC8246806
http://europepmc.org/articles/PMC8246806
Autor:
Seung-Chul Lee, Min Kyung Shin, Young Ja Lee, Byung Soo Kim, Joo Heung Lee, Min Geol Lee, Joo Young Roh, Sang Woong Youn, Yong Beom Choe, Jee Ho Choi, Jeung Hoon Lee, Jingzhi Jiang, Eun-So Lee, Dae Young Yu, Tae-Yoon Kim, Seong Jin Jo
Publikováno v:
Journal of Dermatological Treatment. 33:535-541
Background: The phase 3 studies, VOYAGE 1 and 2, were conducted to assess guselkumab in the treatment of patients with moderate-to-severe psoriasis.Objectives: To investigate the efficacy and safety of guselkumab in Korean patients.Methods: The Korea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99888376db6efd02d96c131ef589d66d
https://doi.org/10.1080/09546634.2020.1770174
https://doi.org/10.1080/09546634.2020.1770174
Autor:
Adriana Guana, Weibin Bao, Tsen-Fang Tsai, Yu Huei Huang, Seung-Chul Lee, Derrick Chen Wee Aw, Joo Heung Lee, Tae-Gyun Kim, Cathleen Michelle A. Dee, Min Geol Lee
Publikováno v:
The Journal of Dermatology. 46:752-758
The 52-week results from the CLEAR (NCT02074982) study showed high and superior efficacy of secukinumab versus ustekinumab in clearing skin and improving patient-reported outcomes, with comparable safety profile in subjects with moderate to severe ps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90601f3462a38ee1733f048068d6a125
https://doi.org/10.1111/1346-8138.15004
https://doi.org/10.1111/1346-8138.15004
Autor:
Sang Woong, Youn, Dae Young, Yu, Tae Yoon, Kim, Byung Soo, Kim, Seung Chul, Lee, Jeung Hoon, Lee, Yong-Beom, Choe, Joo-Heung, Lee, Jee-Ho, Choi, Joo Young, Roh, Seong Jin, Jo, Eun-So, Lee, Min Kyung, Shin, Min-Geol, Lee, Jingzhi, Jiang, YoungJa, Lee
Publikováno v:
The Journal of dermatological treatment. 33(1)
The phase 3 studies, VOYAGE 1 and 2, were conducted to assess guselkumab in the treatment of patients with moderate-to-severe psoriasis.To investigate the efficacy and safety of guselkumab in Korean patients.The Korean sub-population of VOYAGE 1 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9324ee22b006200b262185d00feec85a
https://pubmed.ncbi.nlm.nih.gov/32419536
https://pubmed.ncbi.nlm.nih.gov/32419536
Autor:
Hae Jun Song, Joo Heung Lee, Joonsoo Park, Nack In Kim, Jai Il Youn, Jae We Cho, Young Suck Ro, Min Soo Jang, Seong Jun Seo, Seok-Kweon Yun, Jie Hyun Jeon, Jee Ho Choi, Bong Seok Shin, Ji Yeoun Lee, Tae-Yoon Kim, Youngdoe Kim, Chul Jong Park, Myung Hwa Kim, Min Geol Lee, Sung Ku Ahn, Byung Soo Kim, Dae Young Yu, Kwang Joong Kim, Ki Ho Kim, Seok-Jong Lee, Young Ho Won, Yong Beom Choe, Sang Woong Youn
Publikováno v:
Annals of Dermatology
BACKGROUND Psoriasis is an immune-mediated, chronic inflammatory disease affecting multiple aspects of patients' lives. Its epidemiology varies regionally; however, nationwide epidemiologic data on psoriasis depicting profile of Korean patients has n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a727d5cdb31415c5c24297aa7f020b0
http://europepmc.org/articles/PMC5500712
http://europepmc.org/articles/PMC5500712
Autor:
Ji-Hye Park, Hyun Jeong Byun, Joo-Heung Lee, Seung Hwan Oh, Jong Hee Lee, Ji-Young Jun, Se Jin Oh, Jun-Mo Yang, Dong-Youn Lee
Publikováno v:
Annals of Dermatology
Drug induced lichen planus like eruption is an uncommon cutaneous adverse effect of several drugs. This appears symmetric eruption of erythematous or violaceous plaques resembling lichen planus on the trunk and extremities. A 50-year-old male present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84d0c2b95f497258ba3e0eabc50c619d
http://europepmc.org/articles/PMC6029972
http://europepmc.org/articles/PMC6029972
Autor:
Ji-Hye Park, Se Jin Oh, Jun-Mo Yang, Dong-Youn Lee, Ji-Young Jun, Jong Hee Lee, Joo-Heung Lee, Seung Hwan Oh
Publikováno v:
JAAD Case Reports, Vol 3, Iss 5, Pp 376-378 (2017)
JAAD Case Reports
JAAD Case Reports
Scleromyxedema is a rare, chronic and progressive disorder of unknown origin characterized by a generalized papular eruption and sclerodermoid induration, with histopathologic features of mucin deposition and fibroblast proliferation.1 The disease is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f87d6d7c8733a19b469fb26032412988
http://www.sciencedirect.com/science/article/pii/S2352512617300851
http://www.sciencedirect.com/science/article/pii/S2352512617300851